Amphetamine-evoked rotation requires newly synthesized dopamine at 14 days but not 1 day after intranigral 6-OHDA and is consistently dissociated from sensorimotor behavior

Behavioural Brain Research

Volumn 200, Issue 1, 2009, Pages 197-207

  Paquette, Melanie A ^a   Marsh, Steven T ^a   Hutchings, Janet E ^a   Castañeda, Eddie ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Methyl p tyrosine; 3 Hydroxybenzyl hydrazine; 6 Hydroxydopamine; Amphetamine; Parkinson's disease; Rotation; Sensorimotor; Substantia nigra pars compacta

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; AMPHETAMINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; METIROSINE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; ENZYME INHIBITION; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GRIP STRENGTH; HEMISPHERE; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ROTATION; SENSORIMOTOR FUNCTION; SPRAGUE DAWLEY RAT; WALKING;

ADRENERGIC AGENTS; ALPHA-METHYLTYROSINE; AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FUNCTIONAL LATERALITY; HAND STRENGTH; HYDRAZINES; MALE; MOTOR ACTIVITY; OXIDOPAMINE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; ROTATION; STATISTICS AS TOPIC; SUBSTANTIA NIGRA; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 62649109277     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.01.017     Document Type: Article

References (104)

1. Altar C.A., Marien M.R., and Marshall J.F. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury. J Neurochem 48 (1987) 390-399
2. Arbuthnott G.W., Fairbrother I.S., and Butcher S.P. Dopamine release and metabolism in the rat striatum: an analysis by "in vivo" brain microdialysis. Pharmac Ther 48 (1990) 281-293
3. Barnéoud P., Descombris E., and Aubin N. Abrous DN Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system. Eur J Neurosci 12 (2000) 322-336
4. Berretta S., Lange N., Bhattacharyya S., Sebro R., Garces J., and Benes F.M. Long-term effects of amygdala GABA receptor blockade on specific subpopulations of hippocampal interneurons. Hippocampus 14 (2004) 876-894
5. Betarbet R., Sherert T.B., Di Monte D.A., and Greenamyre T. Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol 12 (2002) 499-510
6. Betarbet R., Sherert T.B., Mackenzie F., Garcia-Osuna M., Panou A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of PD. Nat Neurosci 3 (2000) 1301-1306
7. Björklund A., Dunnett S.B., Stenevi U., Lewis M.E., and Iversen S.D. Reinnervation of the denervated striatum by substantia nigra transplant: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res 199 (1980) 307-333
8. Blandini F., Levandis G., Bazzini E., Nappi G., and Armentero M.T. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci 25 (2007) 397-405
9. Borlongan C.V., Emerich D.F., Hoffer B.J., and Bartus R.T. Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity. Brain Res 956 (2002) 211-220
10. Borlongan C.V., and Sanberg P.R. Elevated body swing test: a new behavioral parameter for rats with 6-OHDA-induced hemiparkinsonism. J Neurosci 15 (1995) 5372-5378
11. Carey R.J. Factors in amphetamine-induced contralateral rotation in the unilateral 6-OHDA lesion rat model during the first-week postoperative: implications for neuropathology and neural grafting. Brain Res 570 (1992) 11-20
12. Carrera M.P., Mattioli R., and Tomaz C. Preoperative operant circling training facilitates recovery following unilateral substantia nigra lesion in rats. Behav Neural Biol 58 (1992) 37-44
13. Carvalho G.A., and Nikkhah G. Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Exp Neurol 171 (2001) 405-417
14. Castañeda E., Fleming S., Paquette M.A., Boat K., Moffett J., Stachowiak E.K., et al. Assessment of recovery in the hemiparkinsonian rat: drug-induced rotation is inadequate. Physiol Behav 84 (2005) 525-535
15. Castañeda E., Whishaw I.Q., Lermer L., and Robinson T.E. Dopamine depletion in neonatal rats: effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood. Brain Res 508 (1990) 30-39
16. Castañeda E., Whishaw I.Q., and Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci 10 (1990) 1847-1854
17. Castañeda E., Whishaw I.Q., and Robinson T.E. Recovery from lateralized neocortical damage: dissociation between amphetamine-induced asymmetry in behavior and striatal dopamine neurotransmission in vivo. Brain Res 571 (1992) 248-259
18. Cheng J.P., Aslam H.A., Hoffman A.N., Zafonte R.D., and Kline A.E. The neurobehavioral benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic window. Neurosci Lett 416 (2007) 165-168
19. Cho J., Duke D., Manzino L., Sonsalla P.K., and West M.O. Dopamine depletion causes fragmented clustering of neurons in the sensorimotor striatum: evidence of lasting reorganization of corticostriatal input. J Comp Neurol 452 (2002) 24-37
20. Cohen A.D., Tillerson J.L., Smith A.D., Schallert T., and Zigmond M.J. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem 85 (2003) 299-305
21. Cole D.G., Kobierski L.A., Konradi C., and Hyman S.E. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc Natl Acad Sci USA 91 (1994) 9631-9635
22. Creese I., Burt D.R., and Snyder S.H. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science 197 (1977) 596-598
23. Da Cunha C., Wietzikoski E.C., Ferro M.M., Martinez G.R., Vital M.A., Hipólide D., et al. Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission. Behav Brain Res 189 (2008) 364-372
24. Döbrössy M.D., and Dunnett S.B. Optimising plasticity: environmental and training associated factors in transplant-mediated brain repair. Rev Neurosci 16 (2005) 1-21
25. Dowd E., and Dunnett S.B. Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats. Behav Brain Res 159 (2005) 153-161
26. Dunnett S.B., Björklund A., Stenevi U., and Iversen S.D. Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res 229 (1981) 209-217
27. Dunnett S.B., Torres E.M., and Annett L.E. A lateralised grip strength test to evaluate unilateral nigrostriatal lesions in rats. Neurosci Lett 246 (1998) 1-4
28. Erickson C.A., Gharbawie O.A., and Whishaw I.Q. Attempt-dependent decrease in skilled reaching characterizes the acute postsurgical period following a forelimb motor cortex lesion: an experimental demonstration of learned nonuse in the rat. Behav Brain Res 179 (2007) 208-218
29. Fairley P.C., and Marshall J.F. Dopamine in the lateral caudate-putamen of the rat is essential for somatosensory orientation. Behav Neurosci 100 (1986) 652-663
30. Fischer J.E., and Cho A.K. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208 (1979) 203-209
31. Gharbawie O.A., Whishaw P.A., and Whishaw I.Q. The topography of three-dimensional exploration: a new quantification of vertical and horizontal exploration, postural support, and exploratory bouts in the cylinder test. Behav Brain Res 151 (2004) 125-135
32. Gorell J.M., Rybicki B.A., Cole Johnson C., and Peterson E.L. Occupation metal exposure and the risk of Parkinson's disease. Neuroepidemiology 18 (1999) 303-308
33. Grunblatt E., Mandel S., and Youdim M.B. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies. J Neurol 247 Suppl 2 (2000) 95-102
34. Jankovic J., Chen S., and Le W.D. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog Neurobiol 77 (2005) 128-138
35. Joyce J.N. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine I Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system. Exp Neurol 113 (1991) 261-276
36. Joyce J.N. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine II Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment. Exp Neurol 113 (1991) 277-290
37. Kahlig K.M., Binda F., Khoshbouei H., Blakely R.D., McMahon D.G., Javitch J.A., et al. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci USA 102 (2005) 3495-3500
38. Karhunen H., Virtanen T., Schallert T., Sivenius J., and Jolkkonen J. Forelimb use after focal cerebral ischemia in rats treated with an α2-adenoreceptor antagonist. Pharmacol Biochem Behav 74 (2003) 663-669
39. Kirik D., Georgievska B., Rosenblad C., and Björklund A. Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease. Eur J Neurosci 13 (2001) 1589-1599
40. Kirik D., Rosenblad C., and Björklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152 (1998) 259-277
41. Kleim J.A., Jones T.A., and Schallert T. Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res 28 (2003) 1757-1769
42. Klein A., Metz G.A., Papazoglou A., and Nikkhah G. Differential effects on forelimb grasping behavior induced by fetal dopaminergic grafts in hemiparkinsonian rats. Neurobiol Dis 27 (2007) 24-35
43. Kostrzewa R.M., Brus R., and Perry K.W. Interactive modulation by dopamine and serotonin neurons of receptor supersensitivity of the alternate neurochemical system. Pol J Pharmacol 51 (1999) 39-47
44. Kostrzewa R.M., Kostrzewa J.P., and Brus R. Dopamine receptor supersensitivity: an outcome and index of neurotoxicity. Neurotox Res 5 (2003) 111-118
45. Labandeira-Garcia J.L., Rozas G., Lopez-Martin E., Liste I., and Guerra M.J. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression. Exp Brain Res 108 (1996) 69-84
46. Langer S.Z., and Arbilla S. The amphetamine paradox in dopaminergic neurotransmission. Trends Pharmacol Sci 5 (1984) 387-390
47. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic parkinsonism in humans due to a product of meperidine analogue synthesis. Science 219 (1983) 979-980
48. Langston J.W., and Irwin I. Organic neurotoxins. In: Calne D.B. (Ed). Neurodegenerative diseases (1994), WB Saunders, Philadelphia 225-240
49. Langston J.W., and Palfreman J. The case of the frozen addicts (1995), Pantheon Books, New York 309 pp.
50. Leviel V., and Guibert B. Involvement of intraterminal dopamine compartments in the amine release in the cat striatum. Neurosci Lett 76 (1987) 197-202
51. Liang N.Y., and Rutledge C.O. Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem Pharmacol 31 (1982) 2479-2484
52. Lopez-Martin E., Rozas G., Rodriguez J., Guerra M.J., and Labandeira-Garcia J.L. The corticostriatal system mediates the "paradoxical" contraversive rotation but not the striatal hyperexpression of Fos induced by amphetamine early after 6-hydroxydopamine lesion of the nigrostriatal pathway. Exp Brain Res 120 (1998) 153-163
53. Lundblad M., Andersson M., Winkler C., Kirik D., Wierup N., and Cenci M.A. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci 15 (2002) 120-132
54. Lynch M.R., and Carey R.J. Amphetamine-induced rotation reveals post 6-OHDA lesion neurochemical reorganization. Behav Brain Res 32 (1989) 69-74
55. Maguire-Zeiss K.A., Mhyre T.R., and Federoff H.J. Gazing into the future: Parkinson's disease gene therapeutics to modify natural history. Exp Neurol 209 (2008) 101-113
56. Mandel S., Grunblatt E., Riederer P., Gerlach M., Levites Y., and Youdim M.B. Neuroprotective strategies in Parkinson's disease: an update on progress. CNS Drugs 17 (2003) 729-762
57. McKenna J.E., and Whishaw I.Q. Complete compensation in skilled reaching success with associated impairments in limb synergies, after dorsal column lesion in the rat. J Neurosci 19 (1999) 1885-1894
58. Metz G.A.S., Schwab M.E., and Welzl H. The effects of acute and chronic stress on motor and sensory performance in male Lewis rats. Physiol Behav 72 (2001) 29-35
59. Metz G.A.S., and Whishaw I.Q. Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance. Neuroscience 111 (2002) 325-336
60. Metz G.A., Antonow-Schlorke I., and Witte O.W. Motor improvements after focal cortical ischemia in adult rats are mediated by compensatory mechanisms. Behav Brain Res 162 (2005) 71-82
61. Metz G.A., Kolb B., and Whishaw I.Q. Neuropsychological tests. In: Whishaw I.Q., and Kolb B. (Eds). The behavior of the laboratory rat: a handbook with tests (2005), Oxford University Press, Cambridge 475-498
62. Miklyaeva E.I., Castañeda E., and Whishaw I.Q. Skilled reaching deficits in unilateral dopamine-depleted rats: impairments in movement and posture and compensatory adjustments. J Neurosci 14 (1994) 7148-7158
63. Miklyaeva E.I., Whishaw I.Q., and Kolb B. A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere. Restor Neurol Neurosci 25 (2007) 91-99
64. Mintz M., Douglas R.J., Tomer R., de Villiers A.S., and Kellaway L. Transient contralateral rotation following unilateral substantia nigra lesion reflects susceptibility of the nigrostriatal system to exhaustion by amphetamine. Life Sci 9 (1986) 69-76
65. Mintz M., and Tomer R. Exposure to amphetamine after substantia nigra lesion interferes with the process of behavioral recovery. Pharm Biochem Behav 25 (1986) 1307-1311
66. Nakagawa T., and Schwartz J.P. Gene expression profiles of reactive astrocytes in dopamine-depleted striatum. Brain Pathol 14 (2004) 275-280
67. Oberlander C., Euvrard C., Dumont C., and Boissier J.R. Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway. Eur J Pharmacol 60 (1979) 163-170
68. Olds M.E., Jacques D.B., and Kopyov O. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions. Synapse 59 (2006) 532-544
69. Parker E.M., and Cubeddu L.X. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum I Release in the absence of vesicular transmitter stores. J Pharmacol Exp Ther 237 (1986) 179-192
70. Pavón N., Vidal L., Alvarez P., Blanco L., Torres A., Rodríguez A., et al. Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by d-amphetamine, apomorphine and the manual dexterity test [Article in Spanish]. Rev Neurol 26 (1998) 915-918
71. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, San Diego 265 pp.
72. Pellis S.M., and Pellis V.C. Posture. In: Whishaw I.Q., and Kolb B. (Eds). The behavior of the laboratory rat: a handbook with tests (2005), Oxford University Press, Cambridge 121-128
73. Petzinger G.M., Walsh J.P., Akopian G., Hogg E., Abernathy A., Arevalo P., et al. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci 27 (2007) 5291-5300
74. Raiteri M.R., Cerrito F., Cervoni A.M., and Levi G. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther 208 (1979) 195-202
75. Robinet P.M., and Bardo M.T. Dopamine D3 receptors are involved in amphetamine-induced contralateral rotation in 6-OHDA lesioned rats. Pharmacol Biochem Behav 70 (2001) 43-54
76. Robinson T.E., Mocsary Z., Camp D.M., and Whishaw I.Q. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci 14 (1994) 2687-2696
77. Robinson T.E., Noordhoorn M., Chan E.M., Mocsary Z., Camp D.M., and Whishaw I.Q. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra. Synapse 17 (1994) 16-25
78. Roghani M., Behzadi G., and Baluchnejadmojarad T. Efficacy of elevated body swing test in the early model of Parkinson's disease in rat. Physiol Behav 76 (2002) 507-510
79. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism, and spinal cord injury. Neuropharmacology 39 (2000) 777-787
80. Schallert T., Upchurch M., Lobaugh N., Farrar S.B., Spirduso W.W., Gilliam P., et al. Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol Biochem Behav 16 (1982) 455-462
81. Schallert T., Hernandez T.D., and Barth T.M. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res 379 (1986) 104-111
82. Schallert T., and Tillerson J. Intervention strategies for degeneration of dopamine neurons in Parkinsonism: optimizing behavioral assessment of outcome. In: Emerich D.F., Dean III R.L., and Sanberg P.R. (Eds). Central nervous system diseases (2001), Humana Press Inc., Totowa, NJ 131-151
83. Schallert T., and Woodlee M.T. Orienting and placing. In: Whishaw I.Q., and Kolb B. (Eds). The behavior of the laboratory rat: a handbook with tests (2005), Oxford University Press, Cambridge 129-140
84. Schapira A.H.V. Mitochondrial dysfunction and oxidative damage in Parkinson's disease. In: Beal M.F., Howell N., and Bodis-Wollner I. (Eds). Mitochondria and free radicals in neurodegenerative diseases (1997), Wiley-Liss, New York 343-359
85. Schwarting R.K., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research analysis of functional deficits, recovery and treatments. Prog Neurobiol 50 (1996) 275-331
86. Schwarz R.D., Uretsky N.J., and Bianchine J.R. The relationship between the stimulation of dopamine synthesis and release produced by amphetamine and high potassium in striatal slices. J Neurochem 35 (1980) 1120-1127
87. Shi L.-H., Woodward D.J., Luo F., Anstrom K., Schallert T., and Chang J.Y. High-frequency stimulation of the subthalamic nucleus reverses limb-use asymmetry in rats with unilateral 6-hydroxydopamine lesions. Brain Res 1013 (2004) 98-106
88. Smith M.P., and Cass W.A. Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease. Neuroscience 144 (2007) 1057-1066
89. Smith A.D., and Zigmond M.J. Can the brain be protected through exercise? Lessons from an animal model of parkinsonism. Exp Neurol 184 (2003) 31-39
90. Tillerson J.L., Caudle W.M., Reveron M.E., and Miller G.W. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience 119 (2003) 899-911
91. Tran-Nguyen L.T.L., Castañeda E., and MacBeth T. Changes in behavior and monoamine levels in microdialysate from dorsal striatum after 6-OHDA infusion into ventral striatum. Pharmacol Biochem Behav 55 (1996) 141-150
92. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Phys Scand 82 Suppl 367 (1971) 49-68
93. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Phys Scand 82 Suppl 367 (1971) 69-93
94. Van Keuren K.R., Stodgell C.J., Schroeder S.R., and Tessel R.E. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model. Brain Res 780 (1998) 56-66
95. Vergara-Aragon P., Gonzalez C.L., and Whishaw I.Q. A novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation. J Neurosci 23 (2003) 579-586
96. Vink R., O'Connor C.A., Nimmo A.J., and Heath D.L. Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats. Neurosci Lett 336 (2003) 41-44
97. Whishaw I.Q. Loss of the innate cortical engram for action patterns used in skilled reaching and the development of behavioral compensation following motor cortex lesions in the rat. Neuropharmacology 39 (2000) 788-805
98. Whishaw I.Q., Coles B.L., Pellis S.M., and Miklyaeva E.I. Impairments and compensation in mouth and limb use in free feeding after unilateral dopamine depletions in a rat analog of human Parkinson's disease. Behav Brain Res 84 (1997) 167-177
99. Whishaw I.Q., Pellis S.M., Gorny B.P., and Pellis V.C. The impairments in reaching and the movements of compensation in rats with motor cortex lesions: an endpoint, videorecording, and movement notation analysis. Behav Brain Res 42 (1991) 77-91
100. Whishaw I.Q., Woodward N.C., Miklyaeva E., and Pellis S.M. Analysis of limb use by control rats and unilateral DA-depleted rats in the Montoya staircase test: movements, impairments and compensatory strategies. Behav Brain Res 89 (1997) 167-177
101. Whishaw I.Q., Zeeb F., Erickson C., and McDonald R.J. Neurotoxic lesions of the caudate-putamen on a reaching for food task in the rat: acute sensorimotor neglect and chronic qualitative motor impairment follow lateral lesions and improved success follows medial lesions. Neuroscience 146 (2007) 86-97
102. Yuan H., Sarre S., Ebinger G., and Michotte Y. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. J Neurosci Methods 144 (2005) 35-45
103. Z'graggen W.J., Metz G.A.S., Kartje G.L., Thallmair M., and Schwab M.E. Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J Neurosci 18 (1998) 4744-4757
104. Zhen X., Torres C., Cai G., and Friedman E. Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's disease. Mol Pharmacol 62 (2002) 1356-1363